The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone (Q71213777)
scientific article published on 01 December 1995
Language:
Current Data About The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone
(P31) (Q13442814)
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P304) 213-225
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P433) 4
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P478) 3
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P577) Friday, December 1, 1995
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P921) (Q6934595)
(P887)

(Q62736)
(P887)

(P1433) (Q7107605)
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P1476) "The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone" (language: en)
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P2093) M E Adams
(P1545) 1
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

M H Atkinson
(P1545) 2
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

A J Lussier
(P1545) 3
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

J I Schulz
(P1545) 4
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

K A Siminovitch
(P1545) 5
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

J P Wade
(P1545) 6
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

M Zummer
(P1545) 7
(P248)
(P698) 8689457
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8689457%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, October 17, 2019

(P2860) (Q36593637)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q72814354)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q34990641)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q70139351)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q43763541)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q34118775)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q37717338)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q67903664)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q70132440)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q68281426)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q35704624)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q44219950)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q69927046)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

(Q72274694)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS1063-4584%2805%2980013-5
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on 01 December 1995

External Links
(P356) 10.1016/S1063-4584(05)80013-5
(P698) 8689457